Cellworks

company

About

Cellworks is a life sciences technology company involved in drug and bio-marker discovery and researches in therapeutic areas.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$13M
Industries
Biotechnology,Health Care,Life Science,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2005
Number Of Employee
51 - 100
Operating Status
Active

Cellworks Group operates as a life sciences technology company. The company provides iC-PHYS, a technology platform that enables drug and biomarker discovery and research in focused therapeutic areas. The company provides disease-focused drug discovery and research solutions in the areas of oncology, such as integrated tumor cell and endothelial cells with stromal inputs; inflammation diseases, such as macrophage, neutrophil, osteoclast, and T-cell; type-2 diabetes; infectious diseases; skin pigmentation and aging; and neurodegenerative.

The company was founded in 2005 and is based in Saratoga, California. It has a research and development facility in Bangalore, India.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$13M
Cellworks has raised a total of $13M in funding over 2 rounds. Their latest funding was raised on Dec 1, 2012 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 1, 2012 Series B $13M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Cellworks is funded by 1 investors. Sequoia Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Sequoia Capital Series B